UK & International Peptide Index & Citations45+ synthetic compounds · 300+ PubMed studies indexed →
TRUSTLYPHARMAUK & Global Peptide Index
Tissue Repair & AngiogenesisCAS: 137525-51-0
Mixed / In Vivo Evidence

BPC-157

Body Protection Compound 157 Pentadecapeptide

BPC-157 is a 15-amino-acid synthetic peptide derived from human gastric juice protein BPC. Preclinical laboratory models investigate its interaction with focal adhesion kinase (FAK), vascular endothelial growth factor receptor 2 (VEGFR2), and early growth response protein 1 (egr-1).

Key Preclinical & Chemical ParametersAnalytical Baseline
Primary Target AxisUpregulation of VEGFR2 transcription and early angiogenic vessel collateralization in ischemic microenvironments.
Lyophilized Storage-20°C desiccated (stable up to 24 months)
Purity Assay BaselineRP-HPLC ≥98.0% · ESI-MS
Standard DiluentBacteriostatic 0.9% Benzyl Alcohol USP or Sterile Purified Water

Indexed for laboratory in vitro receptor binding assays and cellular synthesis research. Commercial materials are procured as non-clinical reagents under verified laboratory standards.

Molecular Anatomy

Chemical Structure & Metrics

Verified CAS
Empirical Molecular Formula:C62H98N16O22
Molecular Weight1419.55 g/mol
Residue Length15 Residues
CAS Registry:137525-51-0
PubChem CID:9941957
Biochemical Class:Tissue Repair & Angiogenesis
N-to-C Residue Chain Preview:
GlyGluProProProGlyLysPro+7 more
Assay Standard:RP-HPLC ≥98% · ESI-MS
Executive Biochemical Summary

Structured Chemical & Preclinical Profile

PubChem & PubMed Indexed

1. Chemical Identity & Sequence Architecture

BPC-157 (Body Protection Compound 157 Pentadecapeptide) is an analytically characterized peptide with empirical formula C62H98N16O22 (MW 1419.55 g/mol). CAS Registry: 137525-51-0.

2. Primary Preclinical Signaling Axis

Investigated in preclinical assays for cellular signaling: Upregulation of VEGFR2 transcription and early angiogenic vessel collateralization in ischemic microenvironments.

3. Physical Formats & Delivery Matrices

Synthesized predominantly as high-purity lyophilized powder cakes, with secondary pre-metered pen cartridges and solution atomizers cataloged across vendors.

4. Reconstitution & Analytical Handling

Recommended reconstitution with Bacteriostatic 0.9% Benzyl Alcohol USP or Sterile Purified Water. Lyophilized cake stored at -20°C desiccated (stable up to 24 months). Solution stable at 2°C to 8°C refrigerated; protect from light (stable 28 days).

Primary Amino Acid Sequence(15 Residues)
Nonpolar Polar Basic Acidic
H₂N-
1Gly
-
2Glu
-
3Pro
-
4Pro
-
5Pro
-
6Gly
-
7Lys
-
8Pro
-
9Ala
-
10Asp
-
11Asp
-
12Ala
-
13Gly
-
14Leu
-
15Val
-COOH
Systematic IUPAC notation: Body Protection Compound 157 Pentadecapeptide
Preclinical Data & Handling

Signaling Pathways & Laboratory Handling Protocols

Documented Receptor Pathways & In Vitro Signaling

1

Upregulation of VEGFR2 transcription and early angiogenic vessel collateralization in ischemic microenvironments.

2

Activation of the FAK-Paxillin phosphorylation cascade, mediating in vitro tendon and ligament fibroblast migration.

3

Modulation of nitric oxide (NO) synthase isoforms (eNOS and iNOS) in capillary endothelium.

4

Downregulation of pro-inflammatory cytokines TNF-alpha and IL-6 in explanted tissue assays.

Investigation Scope

Extensively cataloged in preclinical animal models for microvascular integrity, soft tissue transection models, and mucosal epithelial cellular barrier integrity. It is handled exclusively for in vitro and laboratory evaluation.

Handling Parameters

Recommended DiluentBacteriostatic 0.9% Benzyl Alcohol USP or Sterile Purified Water
Lyophilized Storage-20°C desiccated (stable up to 24 months)
Reconstituted Storage2°C to 8°C refrigerated; protect from light (stable 28 days)
Stability WindowReconstituted solution degrades above 25°C or under repeated freeze-thaw cycles
INTERACTIVE LABORATORY DILUTION TOOL

Peptide Dilution & Reconstitution Calculator

Compute stock concentrations, micro-pipetting draw volumes, and U-100 syringe units with zero procedural guesswork.

5 mg
2 mL
250 mcg
100 Units Capacity
Dilution Formula Derivation:
Concentration =5,000 mcg÷2 mL=2500 mcg/mL
Draw Volume =250 mcg÷2500 mcg/mL=0.100 mL(10.0 Units)
Volumetric Dispensing CalibrationU-100 Standard
Draw to on 1 mL U-100 Syringe:
10.0 Units
Exact Liquid Volume: 0.100 mL (approx. 10 tick marks)
0 UBarrel Fill: 10%100 U
Stock Concentration2.50 mg/mL(2500 mcg/mL)
Aliquot Yield Per Vial20 Aliquots(5,000 mcg total)
Laboratory Reconstitution Protocol:

Slowly introduce bacteriostatic diluent against the internal glass vial wall. Swirl gently in a circular horizontal rotation. Never shake or vortex vigorously to prevent mechanical shearing of delicate peptide bonds. Store reconstituted stock at 2°C–8°C.

Verified Reagent Partners & Vendors

Partner & Vendor Catalogues for BPC-157

Independent partner directory providing research-grade lyophilized vials, cartridges, atomizers, and reconstitution solvents.

5 Verified Partner Catalogues
PharmaGrade logo
PharmaGradepharmagrade.store
Category Hub (All Formats)·United Kingdom / Worldwide

Category hub featuring research-grade lyophilized vials, pens, and blends.

Catalog Purity Spec≥99.2% (HPLC)
Product FormatAll Available Formats
Direct Peptides logo
Direct Peptidesdirect-peptides.com
Category Hub (All Formats)·Worldwide

Full catalogue category hub with multiple mg vial sizes and blends.

Catalog Purity Spec≥99.1% (HPLC)
Product FormatAll Available Formats
Direct Sarms logo
Direct Sarmsdirect-sarms.com
Category Hub (All Formats)·United Kingdom / International

Dedicated category hub listing research vials and cartridges.

Catalog Purity Spec≥98.9% (HPLC)
Product FormatAll Available Formats
Peptide Works logo
Peptide Workspeptide-works.com
Category Hub (All Formats)·United Kingdom / EU

UK-stocked research reagent catalogue hub featuring batch-verified peptide lots.

Catalog Purity Spec≥99.0% (HPLC)
Product FormatAll Available Formats
PharmaLab Global logo
PharmaLab Globalpharmalabglobal.com
Category Hub (All Formats)·Global Dispatch

Global catalogue hub including international dispatch batches.

Catalog Purity Spec≥99.3% (HPLC)
Product FormatAll Available Formats
Peer-Reviewed Literature

Academic Bibliography & Preclinical Studies for BPC-157

Primary academic indexing sourced from PubMed and peer-reviewed biotechnology journals documenting molecular mechanisms and in vitro cellular response.

3 Indexed Papers

Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications

Current Neuropharmacology·Published: 2018·Authors: Sikiric P, Seiwerth S, Rucman R, Turkovic B, et al.
Documented Laboratory Observation:Demonstrated stabilization of cellular membranes, attenuation of endothelial dysfunction, and accelerated microvascular repair cascades in preclinical models.

Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts

Molecules·Published: 2011·Authors: Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH.
Documented Laboratory Observation:Revealed dose-dependent upregulation of growth hormone receptor mRNA expression and activation of the FAK-Paxillin phosphorylation cascade.

BPC 157 and blood vessels: Modulation of angiogenesis and endothelial integrity

Current Pharmaceutical Design·Published: 2014·Authors: Seiwerth S, Rucman R, Turkovic B, Sever M, et al.
Documented Laboratory Observation:Quantified rapid collateral vessel recruitment bypassing vascular occlusions via VEGF expression enhancement in ex vivo tissues.
BIOCHEMICAL REFERENCE Q&A

Frequently Asked Chemical & Analytical Questions

Authoritative scientific clarifications regarding BPC-157 classification, molecular pathways, and laboratory protocols.

4 Curated Questions

BPC-157 (Body Protection Compound 157 Pentadecapeptide) is an analytically characterized peptide compound with empirical molecular formula C62H98N16O22 and molecular weight 1419.55 g/mol. It is indexed under CAS Registry Number 137525-51-0 and categorized in research literature under Tissue Repair & Angiogenesis.

DirectoryCalculatorRegulatoryVendors